# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Approximately 5,079,000 Ordinary Shares Outstanding Post-Split; Trading On Nasdaq Capital Market Begins July 25, 2024, And On T...
More than one dozen novel microbes identified for row crops suffering from extreme weather conditionsTEL AVIV and REHOVOT, Isra...
Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), is pleased to ann...
Casterra Ag Ltd., a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), is a provider of an integrated solution for industri...
Evogene Ltd. released its fourth-quarter and full-year 2023 financial results, showing a 237% revenue increase for the year. De...
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7....